207 related articles for article (PubMed ID: 22374253)
1. Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeys.
Schulze DR; Carroll FI; McMahon LR
Psychopharmacology (Berl); 2012 Aug; 222(3):425-38. PubMed ID: 22374253
[TBL] [Abstract][Full Text] [Related]
2. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
Stewart JL; McMahon LR
J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
[TBL] [Abstract][Full Text] [Related]
3. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
Ginsburg BC; Schulze DR; Hruba L; McMahon LR
J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
[TBL] [Abstract][Full Text] [Related]
4. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
Psychopharmacology (Berl); 2009 Apr; 203(2):219-28. PubMed ID: 18592221
[TBL] [Abstract][Full Text] [Related]
5. Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys.
McMahon LR
Drug Alcohol Depend; 2016 Aug; 165():87-93. PubMed ID: 27289270
[TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
McMahon LR
Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
McMahon LR
J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
[TBL] [Abstract][Full Text] [Related]
8. Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids.
McMahon LR
Br J Pharmacol; 2011 Mar; 162(5):1060-73. PubMed ID: 21091643
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
McMahon LR; Ginsburg BC; Lamb RJ
Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
[TBL] [Abstract][Full Text] [Related]
10. The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys.
Hruba L; McMahon LR
Eur J Pharmacol; 2014 Mar; 727():35-42. PubMed ID: 24486701
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus effects of the cannabinoid antagonist, SR 141716A, in delta -sup-9-tetrahydrocannabinol-treated rhesus monkeys.
McMahon LR; France CP
Exp Clin Psychopharmacol; 2003 Nov; 11(4):286-93. PubMed ID: 14599262
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys.
Wiley JL; Lowe JA; Balster RL; Martin BR
J Pharmacol Exp Ther; 1995 Oct; 275(1):1-6. PubMed ID: 7562536
[TBL] [Abstract][Full Text] [Related]
13. The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys.
Stewart JL; McMahon LR
Br J Pharmacol; 2011 Sep; 164(2b):655-66. PubMed ID: 21449917
[TBL] [Abstract][Full Text] [Related]
14. Apparent Affinity Estimates and Reversal of the Effects of Synthetic Cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by Rimonabant in Rhesus Monkeys.
Hruba L; McMahon LR
J Pharmacol Exp Ther; 2017 Aug; 362(2):278-286. PubMed ID: 28533288
[TBL] [Abstract][Full Text] [Related]
15. SR 141716A differentially attenuates the behavioral effects of delta9-THC in rhesus monkeys.
McMahon LR; Amin MR; France CP
Behav Pharmacol; 2005 Sep; 16(5-6):363-72. PubMed ID: 16148440
[TBL] [Abstract][Full Text] [Related]
16. JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects.
Rodriguez JS; McMahon LR
Eur J Pharmacol; 2014 Oct; 740():151-9. PubMed ID: 24972243
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.
Vann RE; Warner JA; Bushell K; Huffman JW; Martin BR; Wiley JL
Eur J Pharmacol; 2009 Aug; 615(1-3):102-7. PubMed ID: 19470387
[TBL] [Abstract][Full Text] [Related]
18. Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception.
Li JX; McMahon LR; Gerak LR; Becker GL; France CP
Psychopharmacology (Berl); 2008 Aug; 199(2):199-208. PubMed ID: 18470505
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys.
Wiley JL; Huffman JW; Balster RL; Martin BR
Drug Alcohol Depend; 1995 Nov; 40(1):81-6. PubMed ID: 8746928
[TBL] [Abstract][Full Text] [Related]
20. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide.
Järbe TU; Lamb RJ; Lin S; Makriyannis A
Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
